Real‐world data on the effectiveness of brodalumab in patients with moderate‐to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study)

Documenti analoghi

• Real‐World Experience of Secukinumab Treatment in Patients with Moderate‐to‐Severe Plaque Psoriasis in Greece: 3‐Year Interim Results of the SERENA Study
  di: Dimitrios Ioannides, et al.
  Pubblicazione: (2024)
• Risk of multiple sclerosis in patients with psoriasis receiving anti‐IL ‐17 agents: A case‐based review
  di: Sotirios G. Tsiogkas, et al.
  Pubblicazione: (2024)
• Survivin as a Promising Biomarker for Patients Under IL17 RA Inhibitor Therapy: A Single‐Center, Pilot Study
  di: Eleftheria Tampouratzi, et al.
  Pubblicazione: (2025)
• Alpha Divergence Losses for Biometric Verification
  di: Koutsianos, Dimitrios, et al.
  Pubblicazione: (2025)
• Synthetic Speech Source Tracing using Metric Learning
  di: Koutsianos, Dimitrios, et al.
  Pubblicazione: (2025)